You are here

Brachytherapy Department


Head
Piotr Wojcieszek, PhD, MD

 
Registration: +48 32 278-92-57
Secretariat: +48 32 278-92-58, +48 32 278-92-60
E-mail: piotr.wojcieszek@gliwice.nio.gov.pl

 


Oncology Centre in Gliwice is a reference center for brachytherapy
(Nucletron B.V.)

The Brachytherapy Department in MSC Memorial Cancer Center and Institute of Oncology in Gliwice is equipped with state-of-art technologies – including high dose rate brachytherapy, intraoperative treatment, up-to-date planning systems and modern afterloaders delivered by Nucletron/Elekta.

Our Brachytherapy Department is centre of excellence for teaching and research. The Department organizes educational courses and training for physicians, medical physicists and RTTs. Our radiation oncologists and physicists provide clinical research. These assure use of the newest schedules and approaches in cancer treatment.

Brachytherapy, in its over centennial history, was focused on local treatment. This means high doses of radiation in the tumor, while minimal dose in surrounding tissues (i.e. conformal treatment). We use iridium (192Ir) sources to deliver high-dose-rate brachytherapy. Many patients are treated from home. Those who we need to observe stay in one of the radiotherapy units.   
 
Our treatment equipment and facilities include:
  • Three MicroSelectron HDR afterloaders,
  • Cone-Beam Computed Tomography,
  • Integrated Brachytherapy Unit (IBU),
  • MasterPlan Planning System linked to IBU, CT and MRI,
  • OncentraProstate combined with trancrectal ultrasound to perform catheters implantation under its guidance and plan dose coverage immediately after.
  • Three fully equipped and shielded operating theatres,
  • mould room for individual applicators.
​Most of our procedures is performed in one of the operating theatres. Radiation physicists follow protocols and quality assurance procedures for high quality and safe treatment. Each patient is followed during and after the treatment.
 
Brachytherapy is a ultimate conformal treatment. It may be used alone or in combination with external beam radiation and/or surgery (in intra- or perioperative sequence). Intracavitary (e.g. gynecological malignancies, lung cancer, esophageal cancer, rectal cancer), interstitial (e.g. prostate cancer, prostate cancer relapse, head and neck tumors, breast cancer, penile cancer, gynecological tumors, keloid) and contact (e.g. skin cancer) brachytherapy are provided by experienced team. 
 
ONCOLOGICAL Diseases:
  • gynaecological tumors (cervical, endometrial and vulvar cancer),
  • breast cancer (APBI and boost),
  • primary and recurrent prostate cancer,
  • head and neck tumors,
  • gastro-interstitial tumors (esophageal, biliary tract, pancreatic, rectal and anal cancer),
  • lung cancer,
  • soft tissue sarcomas (also peritoneal localization). 

NON-ONCOLOGICAL Diseases:
  • keloid.

Photos